These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 35298487)

  • 41. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA; Dada S; Martin CE; Mullick S
    J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
    Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa.
    Hendrickson C; Hirasen K; Mongwenyana C; Benade M; Bothma R; Smith C; Meyer J; Nichols B; Long L
    medRxiv; 2023 Aug; ():. PubMed ID: 37645864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Multicomponent Intervention to Train and Support Family Medicine Providers to Promote Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in the Deep South: Protocol for the PrEP-Pro Study.
    Isehunwa OO; Hill SV; Menninger AT; Hubner B; Krakower D; Long DM; Pratt MC; Clement ME; Wagoner NV; Lanzi RG; Simpson T; Elopre L; Matthews LT
    JMIR Res Protoc; 2023 Mar; 12():e44908. PubMed ID: 36943364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
    Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
    J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
    Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
    Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Effect of PrEP Use Disclosure on Adherence in a Cohort of Adolescent Girls and Young Women in South Africa.
    Giovenco D; Pettifor A; Powers KA; Hightow-Weidman L; Pence BW; Edwards JK; Gill K; Morton JF; van der Straten A; Celum C; Bekker LG
    AIDS Behav; 2022 Apr; 26(4):1007-1016. PubMed ID: 34478015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving HIV pre-exposure prophylaxis persistence among adolescent girls and young women: Insights from a mixed-methods evaluation of community, hybrid, and facility service delivery models in Namibia.
    Barnabee G; O'Bryan G; Ndeikemona L; Billah I; Silas L; Morgan KL; Shulock K; Mawire S; MacLachlan E; Nghipangelwa J; Muremi E; Ensminger A; Forster N; O'Malley G
    Front Reprod Health; 2022; 4():1048702. PubMed ID: 36545490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incremental costs of integrated PrEP provision and effective use counselling in community-based platforms for adolescent girls and young women in South Africa: an observational study.
    Mudimu E; Sardinia J; Momin S; Medina-Marino A; Bezuidenhout C; Bekker LG; Barnabas RV; Peebles K
    J Int AIDS Soc; 2022 Feb; 25(2):e25875. PubMed ID: 35129299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
    PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research.
    Irungu E; Khoza N; Velloza J
    Curr HIV/AIDS Rep; 2021 Dec; 18(6):490-499. PubMed ID: 34719745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A; Ssemata AS; Muhumuza R; Atujuna M; Abaasa A; Ndekezi D; Tshabalala G; Nematadzira T; Hornschuh S; Nomvuyo M; Ahmed N; Maluadzi M; Anne Weiss H; Webb E; Stranix-Chibanda L; Janine Dietrich J; Seeley J; Fox J
    PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.
    Roberts ST; Hartmann M; Minnis AM; Otticha SO; Browne EN; Montgomery ET; Agot K
    J Int AIDS Soc; 2023 Dec; 26(12):e26198. PubMed ID: 38123866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol.
    Birdthistle I; Schaffnit SB; Kwaro D; Shahmanesh M; Ziraba A; Kabiru CW; Phillips-Howard P; Chimbindi N; Ondeng'e K; Gourlay A; Cowan FM; Hargreaves JR; Hensen B; Chiyaka T; Glynn JR; Floyd S
    BMC Public Health; 2018 Jul; 18(1):912. PubMed ID: 30045711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
    Joseph Davey DL; Dovel K; Cleary S; Khadka N; Mashele N; Silliman M; Mvududu R; Nyemba DC; Coates TJ; Myer L
    BMC Public Health; 2022 Jul; 22(1):1306. PubMed ID: 35799121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility and preliminary effectiveness of integrating HIV prevention into an adolescent empowerment and livelihood intervention at youth clubs in rural Uganda.
    Christian C; Kabami J; Kwarisiima D; Beinamatsiko B; Nakato H; Khakshi JW; Sulaiman M; Komugisha A; Thirumurthy H; Havlir DV; Kamya MR; Chamie G
    AIDS Care; 2023 Jan; 35(1):41-47. PubMed ID: 36473203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.